ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation-Reference-Cited by-同舟云学术

ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation

Published:2022-12 Issue:12 Volume:20 Page:2797-2809
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Deconinck Shannen J.^ORCID,Nix Christoph^ORCID,Barth Svenja^ORCID,Bennek‐Schöpping Eveline^ORCID,Rauch Antoine^ORCID,Schelpe An‐Sofie^ORCID,Roose Elien^ORCID,Feys Hendrik B.^ORCID,Pareyn Inge^ORCID,Vandenbulcke Aline^ORCID,Muia Joshua^ORCID,Vandenbriele Christophe^ORCID,Susen Sophie^ORCID,Meyns Bart^ORCID,Tersteeg Claudia^ORCID,Jacobs Steven^ORCID,De Meyer Simon F.^ORCID,Vanhoorelbeke Karen^ORCID

Funder

KU Leuven

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15889

Reference55 articles.

1. Evolution of left ventricular assist device therapy for advanced heart failure: a review;Miller;JAMA Cardiol,2018

2. Advanced heart failure: prevalence, natural history, and prognosis;Chaudhry;Heart Fail Clin,2016

3. Use of ventricular assist devices and heart transplantation for advanced heart failure;Miller;Circ Res,2019